QH-II-66

From WikiMD's WELLNESSPEDIA

QH-II-66 is a drug that belongs to the benzodiazepine class of medications. It is a sedative and anxiolytic drug that was developed by the China-based company, Qihuang Pharmaceutical.

History[edit]

QH-II-66 was first synthesized in the late 20th century by Qihuang Pharmaceutical. The drug was developed as part of a larger effort to create new benzodiazepine derivatives with improved therapeutic properties.

Pharmacology[edit]

Like other benzodiazepines, QH-II-66 works by enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA) at the GABAA receptor, resulting in sedative, sleep-inducing (hypnotic), anxiolytic (anti-anxiety), anticonvulsant, and muscle relaxant properties.

Medical Uses[edit]

QH-II-66 is primarily used for the treatment of anxiety disorders, insomnia, and seizure disorders. It may also be used as a premedication for medical or dental procedures.

Side Effects[edit]

Common side effects of QH-II-66 include drowsiness, dizziness, and loss of coordination. More serious side effects may include memory problems, depression, and addiction.

See Also[edit]

Stub icon

This medical article is a stub. You can help WikiMD by expanding the page.


  • QH-II-66
    QH-II-66
  • QH-II-66
    QH-II-66

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=QH-II-66&oldid=6334169"